Skip to content

Nursing Care of Bipolar Patients With Sleeping Disorders Using Luminotherapy and /or Psychoeducation Program (BIPLUMINO)

Prise en Charge infirmière Des Anomalies du Sommeil et du Rythme Circadien Par luminothérapie et/ou un Programme Court de psychoéducation Chez Des Patients Souffrant de Troubles Bipolaires

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04917419
Acronym
BIPLUMINO
Enrollment
170
Registered
2021-06-08
Start date
2022-12-05
Completion date
2026-12-31
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Brief summary

Bipolar disorder affects more than 1% of the population. This pathology is considered as one of the most serious psychiatric disorder because of it is high suicide rates. It impacts patients life quality on many aspects, and specially their sleeping and circadian Rhythms. This can lead to more severe symptoms up to for thymic relapses. It was shown that Luminotherapy and Psychoeducation Program have a positive impact on these type of symptoms.

Interventions

OTHERLuminotherapy and /or Psychoeducation Program

TO complete

Sponsors

Centre Hospitalier Henri Laborit
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Main inclusion Criteria: * Bipolar disorder (type 1 and 2 according to DSM V) * Mood Disorder Questionnaire MDQ ˂ 7 * Sleeping and Circadian Rhythms Disorders * Under treatment Main

Exclusion criteria

* No addiction except for tobacco * Narcolepsy * Sleep Apnea * Psychiatric comorbidities * Suicidal ideation

Design outcomes

Primary

MeasureTime frameDescription
Number of days in-hospitalDay 0 to Day 365Number of days patients spent in the hospital

Countries

France

Contacts

Primary ContactCécile BOISVERT
cecile.boisvert@ch-poitiers.fr0033 5 16 52 61 18

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026